Bioorganic & Medicinal Chemistry 1997-12-01

Antitumor agents--CLXXV. Anti-tubulin action of (+)-thiocolchicine prepared by partial synthesis.

Q Shi, P Verdier-Pinard, A Brossi, E Hamel, K H Lee

Index: Bioorg. Med. Chem. 5(12) , 2277-82, (1997)

Full Text: HTML

Abstract

(+)-Thiocolchicine (2b) was prepared from (+/-)-colchicine (1) in a five-step reaction sequence that included chromatographic separation of appropriate camphanylated diastereomers. Acid hydrolysis of the (+)-diastereomer, followed by acetylation, yielded the desired product 2b. (+)-Thiocolchicine has 15-fold lower inhibitory activity against tubulin polymerization than (-)-thiocolchicine, and is 29-fold less potent for inhibiting growth of human Burkitt lymphoma cells. The enantiomer 2a, prepared from the (-)-camphanylated diastereomer, had potent activity in all assays comparable to that of (-)-thiocolchicine prepared by other methods. These results support the hypothesis that the proper configuration of colchicine-related compounds is an important requirement for their anti-tubulin action.


Related Compounds

Related Articles:

Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines.

1998-01-01

[Anticancer Drug Des. 13 , 19-33, (1998)]

Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors.

2005-01-01

[Biochem. Pharmacol. 69(1) , 113-21, (2005)]

Derivatives of thiocolchicine and its applications to CEM cells treatment using 19F magnetic resonance ex vivo.

2010-02-01

[Bioorg. Chem. 38(1) , 1-6, (2010)]

Association of thiocolchicine with tubulin.

1989-06-15

[Biochem. Biophys. Res. Commun. 161(2) , 544-50, (1989)]

Comparative pharmacokinetics and bioavailability of two oral formulations of thiocolchicoside, a GABA-mimetic muscle relaxant drug, in normal volunteers.

1995-01-01

[Eur. J. Drug Metab. Pharmacokinet. 20(4) , 301-5, (1995)]

More Articles...